Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-25,000
Closed -$8.18M 1515
2025
Q4
$8.18M Buy
+25,000
New +$7.93M 0.06% 381
2025
Q3
Sell
-6,000
Closed -$1.68M 1639
2025
Q2
$1.68M Buy
+6,000
New +$1.7M 0.02% 776
2025
Q1
Sell
-27,000
Closed -$7.04M 1474
2024
Q4
$7.04M Buy
27,000
+16,000
+145% +$4.75M 0.07% 274
2024
Q3
$3.54M Sell
11,000
-10,000
-48% -$3.27M 0.06% 385
2024
Q2
$6.56M Buy
21,000
+10,000
+91% +$2.94M 0.1% 211
2024
Q1
$3.13M Hold
11,000
0.05% 418
2023
Q4
$3.17M Buy
+11,000
New +$3M 0.04% 487
2023
Q1
Sell
-41,400
Closed -$10.9M 1058
2022
Q4
$10.9M Buy
41,400
+13,400
+48% +$3.59M 0.17% 151
2022
Q3
$6.31M Buy
+28,000
New +$6.79M 0.09% 273
2022
Q2
Sell
-85,000
Closed -$20.6M 1415
2022
Q1
$20.6M Buy
+85,000
New +$19.5M 0.25% 79
2021
Q3
Sell
-1,000
Closed -$244K 1482
2021
Q2
$244K Buy
+1,000
New +$246K ﹤0.01% 1156
2020
Q3
Sell
-50,000
Closed -$11.8M 1012
2020
Q2
$11.8M Buy
+50,000
New +$11.4M 0.39% 41

Other funds holding AMGN

Caption Management's AMGN Position: Q2 2025 in Review

Caption Management sold out of Amgen (AMGN) in Q2 2025, closing a stake of 7,550 shares — an estimated $2.14M sold.

Caption Management first reported a position in AMGN in Q1 2021 and held it in 7 quarters. The position peaked at $23.6M in Q1 2021. 2,851 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.

  • Caption Management reported no remaining Amgen position as of Q2 2025 after selling out during the quarter.
  • Caption Management sold 7,550 Amgen shares in Q2 2025, an estimated $2.14M.
  • Caption Management first reported a position in Amgen in Q1 2021 and held it in 7 quarters.
  • Caption Management's Amgen position peaked at $23.6M in Q1 2021.
  • 2,851 funds tracked by Wall St. Rank held Amgen as of Q2 2025.

Based on Caption Management's 13F filing for Q2 2025, filed 14 Aug 2025.